Biotechnology Shares of plasma-based company China Biologic Products Holdings leapt 10.5% to $113.99 yesterday after it revealed receipt of a preliminary non-binding proposal letter, dated September 18, 2019, from a consortium of six buyers, including Beachhead Holdings Limited and CITIC Capital China Partners, proposing to acquire all of the outstanding ordinary shares of the company not already owned by the Buyer Group for $120 per share in cash in a "going private" transaction. 20 September 2019